| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | — |
| Cost of Revenue | $2.0M | — |
| Gross Profit | $13K | — |
| R&D Expense | $6.4M | +0.9% |
| SG&A Expense | $8.7M | +35.0% |
| Operating Income | -$15.1M | -18.1% |
| Pre-tax Income | $75.3M | +573.1% |
| Income Tax | $11.3M | +255.3% |
| Net Income | $64.0M | +435.3% |
| EPS (Basic) | $1.53 | +418.8% |
| EPS (Diluted) | $1.50 | +412.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.9M | -15.6% |
| Short-term Investments | $5.4M | +57.4% |
| Current Assets | $133.3M | -6.9% |
| Total Assets | $230.9M | +48.7% |
| Current Liabilities | $19.1M | +235.7% |
| Stockholders' Equity | $199.7M | +36.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -8.7% |
| Capital Expenditures | $9K | -50.0% |
| Investing Cash Flow | $5.4M | -94.9% |
| Financing Cash Flow | -$4.7M | +90.9% |
| Free Cash Flow | -$9.2M | -8.6% |